Nociceptin/orphanin FQ receptor structure, signaling, ligands, functions, and interactions with opioid systems

L Toll, MR Bruchas, BM Cox, NT Zaveri - Pharmacological reviews, 2016 - ASPET
The NOP receptor (nociceptin/orphanin FQ opioid peptide receptor) is the most recently
discovered member of the opioid receptor family and, together with its endogenous ligand …

Calcium-permeable ion channels in pain signaling

E Bourinet, C Altier, ME Hildebrand… - Physiological …, 2014 - journals.physiology.org
The detection and processing of painful stimuli in afferent sensory neurons is critically
dependent on a wide range of different types of voltage-and ligand-gated ion channels …

Opioid receptors

M Waldhoer, SE Bartlett… - Annual review of …, 2004 - annualreviews.org
▪ Abstract Opioid receptors belong to the large superfamily of seven transmembrane-
spanning (7TM) G protein-coupled receptors (GPCRs). As a class, GPCRs are of …

Opioids: first lessons from knockout mice

BL Kieffer, BL Kieffer - Trends in pharmacological sciences, 1999 - cell.com
Opioid receptors of the μ-, δ-and κ-subtypes mediate the potent analgesic and addictive
actions of opioid drugs. They also regulate responses to pain, stress and emotions when …

Endogenous opioid systems alterations in pain and opioid use disorder

JA Higginbotham, T Markovic, N Massaly… - Frontiers in systems …, 2022 - frontiersin.org
Decades of research advances have established a central role for endogenous opioid
systems in regulating reward processing, mood, motivation, learning and memory …

Mu opioid receptor: a gateway to drug addiction

C Contet, BL Kieffer, K Befort - Current opinion in neurobiology, 2004 - Elsevier
Mu opioid receptors mediate positive reinforcement following direct (morphine) or indirect
(alcohol, cannabinoids, nicotine) activation, and our understanding of mu receptor function …

Buprenorphine: a unique drug with complex pharmacology

K Lutfy, A Cowan - Current neuropharmacology, 2004 - ingentaconnect.com
Buprenorphine, an opioid with mixed agonist-antagonist activity at classical opioid
receptors, has been approved recently for the treatment of opioid dependency …

The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential

DG Lambert - Nature reviews Drug discovery, 2008 - nature.com
Identification of the enigmatic nociceptin/orphanin FQ peptide (N/OFQ) in 1995 represented
the first successful use of reverse pharmacology and led to deorphanization of the N/OFQ …

Opioids in chronic pain

R Przewłocki, B Przewłocka - European journal of pharmacology, 2001 - Elsevier
The advance in our understanding of the biogenesis of various endogenous opioid
peptides, their anatomical distribution, and the characteristics of the multiple receptors with …

The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence

JM Witkin, MA Statnick, LM Rorick-Kehn… - Pharmacology & …, 2014 - Elsevier
Abstract Nociceptin/Orphanin FQ (N/OFQ) is a 17 amino acid peptide that was deorphanized
in 1995. The generation of specific agonists, antagonists and receptor deficient mice and …